13 results
8-K
EX-99.1
QLGN
Qualigen Therapeutics Inc
2 Jun 22
Qualigen Therapeutics Acquires Majority Stake in Infectious
9:10am
technology to market sooner.”
“We are excited about beginning a new journey with Qualigen and joining forces in a common mission to develop innovative
8-K
EX-99.1
QLGN
Qualigen Therapeutics Inc
13 May 22
Qualigen Therapeutics, Inc. Provides Corporate Update
6:05am
in the first quarter of 2022 as we executed on our mission of putting patients first while maximizing stakeholder value as a diversified life sciences
8-K
EX-99.1
QLGN
Qualigen Therapeutics Inc
4 May 22
Qualigen Therapeutics to Acquire Majority Stake in Diagnostics Technology Company NanoSynex
4:06pm
as a diversified life sciences company.”
“We are proud to join in Qualigen’s mission to develop innovative diagnostics. NanoSynex and Qualigen share the same goal
424B3
o6f 4i3h7ous
9 Apr 20
Prospectus supplement
9:30am
S-4/A
gl6sn
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4
diiw c2yczmzm
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
8-K
EX-99.1
rjh270p
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
425
EX-99.1
bg0bmn9yc3
21 Jan 20
Business combination disclosure
9:19am
8-K
EX-99.1
rwis07s6g8no
7 May 18
Entry into a Material Definitive Agreement
6:03am
- Prev
- 1
- Next